providers

On May 20th, RxRevu and UCHealth leaders hosted a thought-provoking conversation about how price transparency tools are changing the way health systems manage the prescribing process.

COVID-19 has gotten the full attention of the world. As health systems adjust to tackle new challenges, they must also continue to plan for a largely unknown future.

Dr. Kevin O’Brien supports RxRevu as Chief Medical Officer, while continuing to work with patients in the specialty of Allergy, Asthma, and Immunology at Immunoe Health Centers in Colorado.

While most Americans know someone with diabetes, diabetics face certain challenges when searching and paying for care. New technology can alleviate some stress for this large portion of the population.

The other day, I was in my doctor’s office for a routine checkup and she asked about my work. When I explained that my company, provides a connection to bring real-time prescription benefit (RTPB) into the prescribing workflow…

This week, 35+ companies stepped up efforts to prevent the spread of COVID-19 here in Colorado and beyond.

For healthcare consumers, the patient financial experience begins the minute they realize they need care. Providing price transparency is only the first step in improving provider/patient cost conversations.

With efforts being made to manage drug pricing on the legislative and regulatory fronts, the technology sector is now looking to provide solutions that will be widely adopted across the industry.

Payers/PBMS, health systems, providers, and patients are actively asking for ways to see the cost of prescriptions prior to a trip to the pharmacy. But there is confusion around how RTPB tools work and how to implement them.

On May 23, 2019, the Trump Administration’s Centers for Medicare & Medicaid Services (CMS) published its Medicare Advantage and Part D Drug Pricing Final Rule…